Assetmark, Inc West Pharmaceutical Services Inc Transaction History

Assetmark, Inc

$41.6 Billion
Q2 2025

A detailed history of Assetmark, Inc transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Assetmark, Inc holds 41,430 shares of WST stock, worth $11.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

41,430

Previous 35,469 16.81%

Holding current value

$11.9 Million

Previous $7.94 Million 14.16%

% of portfolio

0.02%

Previous 0.02%

37 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 04, 2025	BUY	$190.39 - $227.7 $1.13 Million - $1.36 Million	5,961 Added 16.81%	41,430 $9.06 Million
Q1 2025 May 06, 2025	BUY	$199.11 - $347.87 $5.46 Million - $9.55 Million	27,439 Added 341.71%	35,469 $7.94 Million
Q4 2024 Feb 06, 2025	BUY	$285.69 - $344.0 $427,677 - $514,968	1,497 Added 22.91%	8,030 $2.63 Million
Q3 2024 Nov 01, 2024	BUY	$277.16 - $333.3 $166,573 - $200,313	601 Added 10.13%	6,533 $1.96 Million
Q2 2024 Aug 13, 2024	BUY	$314.68 - $395.94 $300,834 - $378,518	956 Added 19.21%	5,932 $1.95 Million
Q1 2024 May 06, 2024	BUY	$338.27 - $413.0 $448,546 - $547,638	1,326 Added 36.33%	4,976 $1.97 Million
Q4 2023 Feb 09, 2024	BUY	$318.29 - $392.21 $334,204 - $411,820	1,050 Added 40.38%	3,650 $1.29 Million
Q3 2023 Oct 27, 2023	BUY	$354.9 - $412.41 $173,191 - $201,256	488 Added 23.11%	2,600 $975,000
Q2 2023 Aug 11, 2023	BUY	$334.63 - $382.47 $240,933 - $275,378	720 Added 51.72%	2,112 $807,000
Q1 2023 May 05, 2023	BUY	$232.5 - $346.47 $105,090 - $156,604	452 Added 48.09%	1,392 $482,000
Q4 2022 Feb 10, 2023	BUY	$209.34 - $261.61 $71,594 - $89,470	342 Added 57.19%	940 $221,000
Q3 2022 Nov 01, 2022	BUY	$246.08 - $343.65 $49,216 - $68,730	200 Added 50.25%	598 $147,000
Q2 2022 Aug 03, 2022	BUY	$280.61 - $420.45 $67,907 - $101,748	242 Added 155.13%	398 $120,000
Q1 2022 May 13, 2022	BUY	$357.49 - $445.92 $54,695 - $68,225	153 Added 5100.0%	156 $64,000
Q3 2021 Nov 12, 2021	BUY	$363.01 - $468.47 $1,089 - $1,405	3 New	3 $1,000
Q2 2021 Aug 16, 2021	SELL	$284.77 - $363.2 $3,986 - $5,084	-14 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$257.29 - $307.53 $771 - $922	3 Added 27.27%	14 $4,000
Q4 2020 Feb 10, 2021	SELL	$261.16 - $301.66 $2,350 - $2,714	-9 Reduced 45.0%	11 $3,000
Q3 2020 Nov 13, 2020	SELL	$224.99 - $288.02 $1,574 - $2,016	-7 Reduced 25.93%	20 $5,000
Q2 2020 Aug 11, 2020	SELL	$149.8 - $227.17 $14,530 - $22,035	-97 Reduced 78.23%	27 $6,000
Q1 2020 May 12, 2020	BUY	$128.96 - $174.76 $11,993 - $16,252	93 Added 300.0%	124 $19,000
Q4 2019 Feb 11, 2020	BUY	$137.6 - $151.21 $275 - $302	2 Added 6.9%	31 $5,000
Q3 2019 Nov 13, 2019	BUY	$121.41 - $150.02 $728 - $900	6 Added 26.09%	29 $4,000
Q1 2019 May 14, 2019	SELL	$94.53 - $110.2 $1,701 - $1,983	-18 Reduced 43.9%	23 $3,000
Q4 2018 Feb 13, 2019	SELL	$93.0 - $123.98 $8,835 - $11,778	-95 Reduced 69.85%	41 $4,000
Q3 2018 Nov 13, 2018	SELL	$98.01 - $123.47 $490 - $617	-5 Reduced 3.55%	136 $17,000
Q2 2018 Aug 01, 2018	BUY	$83.32 - $101.88 $1,166 - $1,426	14 Added 11.02%	141 $14,000
Q1 2018 May 16, 2018	SELL	$85.56 - $102.4 $53,731 - $64,307	-628 Reduced 83.18%	127 $11,000
Q4 2017 Feb 13, 2018	SELL	$91.65 - $101.65 $2,291 - $2,541	-25 Reduced 3.21%	755 $75,000
Q3 2017 Nov 08, 2017	SELL	$84.54 - $96.75 $84 - $96	-1 Reduced 0.13%	780 $75,000
Q2 2017 Aug 15, 2017	SELL	N/A	-100 Reduced 11.35%	781 $74,000
Q1 2017 Sep 15, 2017	BUY	N/A	1 Added 0.11%	881 $72,000
Q4 2016 Sep 15, 2017	SELL	N/A	-9 Reduced 1.01%	880 $75,000
Q3 2016 Sep 15, 2017	SELL	N/A	-101 Reduced 10.2%	889 $66,000
Q2 2016 Sep 15, 2017	SELL	N/A	-12 Reduced 1.2%	990 $75,000
Q1 2016 Sep 15, 2017	BUY	N/A	24 Added 2.45%	1,002 $69,000
Q4 2015 Sep 15, 2017	BUY	N/A	978	978 $59,000

Others Institutions Holding WST

# of Institutions

842

Shares Held

68.6M

Call Options Held

344K

Put Options Held

144K

View Full List

About WEST PHARMACEUTICAL SERVICES INC

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $21.2B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

More about WST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Account